{"transactions":[{"id":4521463,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":180382,"kind":"person","name":"LaVallee Theresa","position":1,"cik":"0001690948","reported_name":"LaVallee Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Reg.& Precision Medicine"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2016-12-15T21:08:57.000Z","date":"2016-12-14","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total amount of shares subject to the Option vests on December 14, 2017 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters, beginning March 14, 2018."}],"balance_after":75000,"derivative":{"exercise_price":3.72,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001179110-16-033001","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911016033001/edgar.xml","form_type":"4"}}]}